These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12644139)

  • 1. Conversion to sirolimus after kidney and liver transplantation: indications and outcomes.
    Wramner L; Norden G; Herlenius G; Friman S; Olausson M; Bäckman L
    Transplant Proc; 2003 Mar; 35(2):791. PubMed ID: 12644139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Consensus-recommendations for sirolimus in liver transplantation].
    Golling M; Becker T; Broelsch C; Candinas D; Faust D; Fischer L; Geissler E; Graeb C; Iberer F; Klupp J; Kraus T; Müller AR; Neuhaus P; Strassburg CP; Wolff M; Zülke C; Bechstein WO
    Z Gastroenterol; 2004 Nov; 42(11):1333-40. PubMed ID: 15558447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus for solid organ transplantation in children.
    Gupta P; Kaufman S; Fishbein TM
    Pediatr Transplant; 2005 Jun; 9(3):269-76. PubMed ID: 15910380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipient--not all proliferation signal inhibitors are the same: a case report.
    De Simone P; Petruccelli S; Precisi A; Carrai P; Doria R; Menichetti F; Filipponi F
    Transplant Proc; 2007 Dec; 39(10):3500-1. PubMed ID: 18089420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching to sirolimus-based immune suppression after liver transplantation is safe and effective: a single-center experience.
    Harper SJ; Gelson W; Harper IG; Alexander GJ; Gibbs P
    Transplantation; 2011 Jan; 91(1):128-32. PubMed ID: 21452417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus in liver transplantation.
    Trotter JF
    Transplant Proc; 2003 May; 35(3 Suppl):193S-200S. PubMed ID: 12742496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
    Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
    J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus therapy in orthotopic liver transplant (OLT) recipients with acute renal insufficiency.
    Montalbano M; Neff GW; Slapak-Green G; Berney T; Meyer D
    Dig Dis Sci; 2004; 49(11-12):1986-9. PubMed ID: 15628739
    [No Abstract]   [Full Text] [Related]  

  • 10. Interstitial pneumonitis associated with sirolimus (rapamycin) therapy after liver transplantation.
    Lennon A; Finan K; FitzGerald MX; McCormick PA
    Transplantation; 2001 Sep; 72(6):1166-7. PubMed ID: 11579321
    [No Abstract]   [Full Text] [Related]  

  • 11. Sirolimus as rescue therapy after liver transplantation.
    Reigada CH; de Ataide EC; de Araújo FR; Ramos AP; Stucchi RS; Eescanhoela CA; Boin IF
    Transplant Proc; 2012 Oct; 44(8):2434-7. PubMed ID: 23026613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient.
    Jankowska I; Oldakowska-Jedynak U; Jabiry-Zieniewicz Z; Cyganek A; Pawlowska J; Teisseyre M; Kalicinski P; Markiewicz M; Paczek L; Socha J
    Transplant Proc; 2004 Dec; 36(10):3232-3. PubMed ID: 15686735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial pneumonitis associated with sirolimus in liver transplantation: a case report.
    Pérez MJ; Martín RO; García DM; Rey JM; de la Cruz Lombardo J; Rodrigo López JM
    Transplant Proc; 2007 Dec; 39(10):3498-9. PubMed ID: 18089419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten years of sirolimus therapy in orthotopic liver transplant recipients.
    Neff GW; Montalbano M; Tzakis AG
    Transplant Proc; 2003 May; 35(3 Suppl):209S-216S. PubMed ID: 12742498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus in patients after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transplant Proc; 2003 Mar; 35(2):815-6. PubMed ID: 12644150
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment: delayed wound healing with sirolimus after liver transplant.
    Mathis AS
    Ann Pharmacother; 2003 Mar; 37(3):453. PubMed ID: 12639183
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus: efficacy in liver transplant patients with nephrotoxicity and renal insufficiency.
    Perdigoto R; Sequeira C; Tomé L; Ferrão J; Silva N; Geraldes J; Furtado E; Oliveira FJ
    Transplant Proc; 2007 Oct; 39(8):2519-21. PubMed ID: 17954163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
    Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
    Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome.
    Perrakis A; Schwarz K; Yedibela S; Croner RS; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3702-7. PubMed ID: 22172830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.